AI
ALXO icon

Atom Investors’s ALX Oncology ALXO Stock Holding History

Atom Investors’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$454K Buy
+219,382
New +$393K 0.04% 584
2022
Q1 		– Sell
-15,477
Closed -$333K – 193
2021
Q4 		$333K Buy
+15,477
New +$668K 0.06% 191

Other funds holding ALXO

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

Atom Investors's ALXO Position: Q2 2026 in Review

Atom Investors opened a new position in ALX Oncology (ALXO) in Q2 2026: 219,382 shares worth $454K. The stake represents 0.04% of the portfolio and ranks #584 among its holdings. This is a return to the name: Atom Investors previously reported a position in ALXO as recently as Q4 2021.

Atom Investors first reported a position in ALXO in Q4 2021 and has held it in 2 quarters since. 93 funds tracked by Wall St. Rank hold ALXO as of Q2 2026.

  • Atom Investors held 219,382 shares of ALX Oncology worth $454K as of Q2 2026.
  • ALX Oncology was a new Atom Investors position in Q2 2026.
  • ALX Oncology made up 0.04% of Atom Investors's portfolio in Q2 2026, its #584 holding.
  • Atom Investors first reported a position in ALX Oncology in Q4 2021 and has held it in 2 quarters since.
  • 93 funds tracked by Wall St. Rank held ALX Oncology as of Q2 2026.

Based on Atom Investors's 13F filing for Q2 2026, filed 14 Aug 2026.